thimmappa kuruva’s Post

Driven by tomorrow, serving science today – Calyx and Invicro have evolved to become Perceptive. With a combined 50+ years of industry expertise, experience, and trust behind us, we’re excited to provide even more clarity and consistency of delivery, speed, and results for your research and clinical trials in our next chapter. Discover how we’re making tomorrow’s new therapies possible and keep up with our latest updates by following us here, or visit our new Perceptive website at ➡️ perceptive.com. #perceptive #calyx #invicro #discovery #imaging #irt #rtsm #eclinical #oncology #rebrand #pharmaceutical

At CALYX, we are deeply committed to corporate social responsibility! Our recent initiative at Ashray Akruti (https://lnkd.in/gpYffsnF) was a tremendous success. We organized a series of life-skill activities for youth with hearing impairments, providing a valuable and enriching experience for everyone involved. Thank you to our committed volunteers, whose enthusiasm and dedication have made a meaningful impact.

Understand where and how unblinding can occur in #ClinicalTrials and how to minimize those risks with these papers, webinars, and blogs produced by Calyx #IRT solution design and technical experts. https://lnkd.in/gkD8sGic #ChooseCalyx #RTSM #Randomization #TrialSupplyManagement 

We are looking for a Scientist specializing in Radiochemistry to join our team at our laboratory in New Haven, CT. This is an exciting opportunity that offers diverse experience and knowledge in PET synthesis, imaging, and medicinal chemistry while working alongside senior stakeholders.   If you are passionate about helping bring life-changing medical treatments to patients in need, we encourage you to apply now: https://lnkd.in/gEPqCdsc

Calyx’s #IRT experts routinely design #RTSM solutions that ensure the right balance between treatment arms, even in protocols with complex #randomization needs. Read the case study. https://lnkd.in/gvd7AdFm #ClinicalTrials #ChooseCalyx #TrialSupplyManagement 

Attending #ESMO2024 next week? Meet with #Calyx's Dr. Oliver Bohnsack, Surabhi Bajpai, and other #MedicalImaging scientists to learn how their vast experience in #Oncology #ClinicalTrial imaging can help your development program succeed. https://lnkd.in/gRYf8P89 #ESMO Anja Urbank Manuela Lesch Lilit Sargsyan-Storim David Griffiths Dr. Zan Bajwa

Heading to #ESMO2024 this week? Meet with #Calyx's Dr. Oliver Bohnsack, Surabhi Bajpai, and other #MedicalImaging scientists to learn how their vast experience in #Oncology #ClinicalTrial imaging can help your development program succeed. https://lnkd.in/g9eFNVFJ #ESMO Manuela Lesch Anja Urbank David Griffiths Dr. Zan Bajwa Invicro

Learn the key considerations for utilizing #RANO 2.0 criteria when assessing #Glioblastoma treatments in #ClinicalTrials. Read the blog. https://lnkd.in/gpJgP9yE #MedicalImaging #NeuroOncology #ChooseCalyx

Learn simple methods to alleviate concerns about regulatory risks, enabling you to realize the many benefits of #MedicationPooling during #ClincialDevelopment. View the webinar now. https://lnkd.in/gbhSrHQt #IRT #RTSM #TrialSupplyManagement #ChooseCalyx

Learn how the therapeutic, modality, and regulatory expertise of your #MedicalImaging provider can make or break your #SolidTumor trial. Read the blog. https://lnkd.in/gmY797hb #ChooseCalyx #ClinicalTrials #Oncology